메뉴 건너뛰기




Volumn 15, Issue 3, 2016, Pages 313-329

Molecular mechanisms for enhanced DNA vaccine immunogenicity

Author keywords

DNA vaccine; immunogenicity; molecular adjuvant; plasmid; vaccine delivery

Indexed keywords

ANTIGEN; CANCER VACCINE; DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLUENZA VACCINE; INTERLEUKIN 10; INTERLEUKIN 15; INTERLEUKIN 2; INTERLEUKIN 21; INTERLEUKIN 6; INTERLEUKIN 7; PATTERN RECOGNITION RECEPTOR; PLASMID DNA; PLASMID VECTOR; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 9; VIRUS VECTOR;

EID: 84959146422     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/14760584.2016.1124762     Document Type: Review
Times cited : (258)

References (176)
  • 1
    • 25144470060 scopus 로고    scopus 로고
    • Current developments in viral DNA vaccines: Shall they solve the unsolved?
    • Rajcani J, Mosko T, Rezuchova I. Current developments in viral DNA vaccines: shall they solve the unsolved? Rev Med Virol. 2005; 15 (5): 303-325.
    • (2005) Rev Med Virol , vol.15 , Issue.5 , pp. 303-325
    • Rajcani, J.1    Mosko, T.2    Rezuchova, I.3
  • 2
    • 61849159893 scopus 로고    scopus 로고
    • DNA vaccines: Developing new strategies to enhance immune responses
    • Abdulhaqq SA, Weiner DB. DNA vaccines: developing new strategies to enhance immune responses. Immunol Res. 2008; 42 (1-3): 219-232.
    • (2008) Immunol Res , vol.42 , Issue.13 , pp. 219-232
    • Abdulhaqq, S.A.1    Weiner, D.B.2
  • 3
    • 78650573649 scopus 로고    scopus 로고
    • DNA vaccines: An historical perspective and view to the future
    • Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev. 2011; 239 (1): 62-84.
    • (2011) Immunol Rev , vol.239 , Issue.1 , pp. 62-84
    • Liu, M.A.1
  • 4
    • 52449104809 scopus 로고    scopus 로고
    • DNA vaccines: Ready for prime time?
    • Kutzler MA, Weiner DB. DNA vaccines: ready for prime time? Nat Rev Genet. 2008; 9 (10): 776-788.
    • (2008) Nat Rev Genet , vol.9 , Issue.10 , pp. 776-788
    • Kutzler, M.A.1    Weiner, D.B.2
  • 5
    • 0025231388 scopus 로고
    • Direct gene transfer into mouse muscle in vivo
    • Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse muscle in vivo. Science. 1990; 247 (4949 Pt 1): 1465-1468.
    • (1990) Science , vol.247 , Issue.4949 , pp. 1465-1468
    • Wolff, J.A.1    Malone, R.W.2    Williams, P.3
  • 6
    • 0026579897 scopus 로고
    • Genetic immunization is a simple method for eliciting an immune response
    • Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature. 1992; 356 (6365): 152-154.
    • (1992) Nature , vol.356 , Issue.6365 , pp. 152-154
    • Tang, D.C.1    DeVit, M.2    Johnston, S.A.3
  • 7
    • 0027411456 scopus 로고
    • Heterologous protection against influenza by injection of DNA encoding a viral protein
    • Ulmer JB, Donnelly JJ, Parker SE, et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science. 1993; 259 (5102): 1745-1749.
    • (1993) Science , vol.259 , Issue.5102 , pp. 1745-1749
    • Ulmer, J.B.1    Donnelly, J.J.2    Parker, S.E.3
  • 8
    • 0027213712 scopus 로고
    • Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA
    • Robinson HL, Hunt LA, Webster RG. Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine. 1993; 11 (9): 957-960.
    • (1993) Vaccine , vol.11 , Issue.9 , pp. 957-960
    • Robinson, H.L.1    Hunt, L.A.2    Webster, R.G.3
  • 9
    • 77952424081 scopus 로고    scopus 로고
    • Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection
    • Faurez F, Dory D, Le Moigne V, et al. Biosafety of DNA vaccines: new generation of DNA vectors and current knowledge on the fate of plasmids after injection. Vaccine. 2010; 28 (23): 3888-3895.
    • (2010) Vaccine , vol.28 , Issue.23 , pp. 3888-3895
    • Faurez, F.1    Dory, D.2    Le Moigne, V.3
  • 10
    • 0034619794 scopus 로고    scopus 로고
    • A Toll-like receptor recognizes bacterial DNA
    • Hemmi H, Takeuchi O, Kawai T, et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000; 408 (6813): 740-745.
    • (2000) Nature , vol.408 , Issue.6813 , pp. 740-745
    • Hemmi, H.1    Takeuchi, O.2    Kawai, T.3
  • 11
    • 77953627757 scopus 로고    scopus 로고
    • Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection
    • Rottembourg D, Filippi CM, Bresson D, et al. Essential role for TLR9 in prime but not prime-boost plasmid DNA vaccination to activate dendritic cells and protect from lethal viral infection. J Immunol. 2010; 184 (12): 7100-7107.
    • (2010) J Immunol , vol.184 , Issue.12 , pp. 7100-7107
    • Rottembourg, D.1    Filippi, C.M.2    Bresson, D.3
  • 12
    • 4444325043 scopus 로고    scopus 로고
    • TLR9-/-and TLR9+/+ mice display similar immune responses to a DNA vaccine
    • Babiuk S, Mookherjee N, Pontarollo R, et al. TLR9-/-and TLR9+/+ mice display similar immune responses to a DNA vaccine. Immunology. 2004; 113 (1): 114-120.
    • (2004) Immunology , vol.113 , Issue.1 , pp. 114-120
    • Babiuk, S.1    Mookherjee, N.2    Pontarollo, R.3
  • 13
    • 12344320234 scopus 로고    scopus 로고
    • TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines
    • Tudor D, Dubuquoy C, Gaboriau V, et al. TLR9 pathway is involved in adjuvant effects of plasmid DNA-based vaccines. Vaccine. 2005; 23 (10): 1258-1264.
    • (2005) Vaccine , vol.23 , Issue.10 , pp. 1258-1264
    • Tudor, D.1    Dubuquoy, C.2    Gaboriau, V.3
  • 14
    • 84878309796 scopus 로고    scopus 로고
    • Cyclic [G(2,5)pA(3,5)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase
    • Gao P, Ascano M, Wu Y, et al. Cyclic [G(2,5)pA(3,5)p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell. 2013; 153 (5): 1094-1107.
    • (2013) Cell , vol.153 , Issue.5 , pp. 1094-1107
    • Gao, P.1    Ascano, M.2    Wu, Y.3
  • 15
    • 84873711885 scopus 로고    scopus 로고
    • Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type i interferon pathway
    • Sun L, Wu J, Du F, et al. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science. 2013; 339 (6121): 786-791.
    • (2013) Science , vol.339 , Issue.6121 , pp. 786-791
    • Sun, L.1    Wu, J.2    Du, F.3
  • 16
    • 84907025040 scopus 로고    scopus 로고
    • The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-beta during Chlamydia trachomatis infection
    • Zhang Y, Yeruva L, Marinov A, et al. The DNA sensor, cyclic GMP-AMP synthase, is essential for induction of IFN-beta during Chlamydia trachomatis infection. J Immunol. 2014; 193 (5): 2394-2404.
    • (2014) J Immunol , vol.193 , Issue.5 , pp. 2394-2404
    • Zhang, Y.1    Yeruva, L.2    Marinov, A.3
  • 17
    • 34547143110 scopus 로고    scopus 로고
    • DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response
    • Takaoka A, Wang Z, Choi MK, et al. DAI (DLM-1/ZBP1) is a cytosolic DNA sensor and an activator of innate immune response. Nature. 2007; 448 (7152): 501-505.
    • (2007) Nature , vol.448 , Issue.7152 , pp. 501-505
    • Takaoka, A.1    Wang, Z.2    Choi, M.K.3
  • 18
    • 38949093002 scopus 로고    scopus 로고
    • TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines
    • Ishii KJ, Kawagoe T, Koyama S, et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature. 2008; 451 (7179): 725-729.
    • (2008) Nature , vol.451 , Issue.7179 , pp. 725-729
    • Ishii, K.J.1    Kawagoe, T.2    Koyama, S.3
  • 19
    • 77951263260 scopus 로고    scopus 로고
    • The AIM2 inflammasome is critical for innate immunity to Francisella tularensis
    • Fernandes-Alnemri T, Yu JW, Juliana C, et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol. 2010; 11 (5): 385-393.
    • (2010) Nat Immunol , vol.11 , Issue.5 , pp. 385-393
    • Fernandes-Alnemri, T.1    Yu, J.W.2    Juliana, C.3
  • 20
    • 62549122914 scopus 로고    scopus 로고
    • Innate immunity: Cytoplasmic DNA sensing by the AIM2 inflammasome
    • Schroder K, Muruve DA, Tschopp J. Innate immunity: cytoplasmic DNA sensing by the AIM2 inflammasome. Curr Biol. 2009; 19 (6): R262-R265.
    • (2009) Curr Biol , vol.19 , Issue.6 , pp. R262-R265
    • Schroder, K.1    Muruve, D.A.2    Tschopp, J.3
  • 21
    • 84920374073 scopus 로고    scopus 로고
    • Identification of Aim2 as a sensor for DNA vaccines
    • Suschak JJ, Wang S, Fitzgerald KA, et al. Identification of Aim2 as a sensor for DNA vaccines. J Immunol. 2015; 194 (2): 630-636.
    • (2015) J Immunol , vol.194 , Issue.2 , pp. 630-636
    • Suschak, J.J.1    Wang, S.2    Fitzgerald, K.A.3
  • 22
    • 84901684203 scopus 로고    scopus 로고
    • Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system
    • Sugimoto N, Mitoma H, Kim T, et al. Helicase proteins DHX29 and RIG-I cosense cytosolic nucleic acids in the human airway system. Proc Natl Acad Sci USA. 2014; 111 (21): 7747-7752.
    • (2014) Proc Natl Acad Sci USA , vol.111 , Issue.21 , pp. 7747-7752
    • Sugimoto, N.1    Mitoma, H.2    Kim, T.3
  • 23
    • 84875224757 scopus 로고    scopus 로고
    • DNA-PK is a DNA sensor for IRF-3-dependent innate immunity
    • Ferguson BJ, Mansur DS, Peters NE, et al. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife. 2012; 1: e00047.
    • (2012) Elife , vol.1 , pp. e00047
    • Ferguson, B.J.1    Mansur, D.S.2    Peters, N.E.3
  • 24
    • 84918789838 scopus 로고    scopus 로고
    • IFI16: At the interphase between innate DNA sensing and genome regulation
    • Jakobsen MR, Paludan SR. IFI16: at the interphase between innate DNA sensing and genome regulation. Cytokine Growth Factor Rev. 2014; 25 (6): 649-655.
    • (2014) Cytokine Growth Factor Rev , vol.25 , Issue.6 , pp. 649-655
    • Jakobsen, M.R.1    Paludan, S.R.2
  • 25
    • 84874278336 scopus 로고    scopus 로고
    • DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type i interferon by regulating STING trafficking
    • Kondo T, Kobayashi J, Saitoh T, et al. DNA damage sensor MRE11 recognizes cytosolic double-stranded DNA and induces type I interferon by regulating STING trafficking. Proc Natl Acad Sci USA. 2013; 110 (8): 2969-2974.
    • (2013) Proc Natl Acad Sci USA , vol.110 , Issue.8 , pp. 2969-2974
    • Kondo, T.1    Kobayashi, J.2    Saitoh, T.3
  • 26
    • 84869403247 scopus 로고    scopus 로고
    • The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type i interferon immune response
    • Parvatiyar K, Zhang Z, Teles RM, et al. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat Immunol. 2012; 13 (12): 1155-1161.
    • (2012) Nat Immunol , vol.13 , Issue.12 , pp. 1155-1161
    • Parvatiyar, K.1    Zhang, Z.2    Teles, R.M.3
  • 27
    • 77958140656 scopus 로고    scopus 로고
    • IFI16 is an innate immune sensor for intracellular DNA
    • Unterholzner L, Keating SE, Baran M, et al. IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol. 2010; 11 (11): 997-1004.
    • (2010) Nat Immunol , vol.11 , Issue.11 , pp. 997-1004
    • Unterholzner, L.1    Keating, S.E.2    Baran, M.3
  • 28
    • 80052969639 scopus 로고    scopus 로고
    • The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells
    • Zhang Z, Yuan B, Bao M, et al. The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells. Nat Immunol. 2011; 12 (10): 959-965.
    • (2011) Nat Immunol , vol.12 , Issue.10 , pp. 959-965
    • Zhang, Z.1    Yuan, B.2    Bao, M.3
  • 29
    • 84908548143 scopus 로고    scopus 로고
    • DNAVaxDB: The first web-based DNA vaccine database and its data analysis
    • Racz R, Li X, Patel M, et al. DNAVaxDB: the first web-based DNA vaccine database and its data analysis. BMC Bioinformatics. 2014; 15 (Suppl 4): S2.
    • (2014) BMC Bioinformatics , vol.15 , pp. S2
    • Racz, R.1    Li, X.2    Patel, M.3
  • 30
    • 0032533471 scopus 로고    scopus 로고
    • Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium
    • Uchijima M, Yoshida A, Nagata T, et al. Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol. 1998; 161 (10): 5594-5599.
    • (1998) J Immunol , vol.161 , Issue.10 , pp. 5594-5599
    • Uchijima, M.1    Yoshida, A.2    Nagata, T.3
  • 31
    • 65449142925 scopus 로고    scopus 로고
    • Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and e by DNA electrotransfer
    • Trollet C, Pereira Y, Burgain A, et al. Generation of high-titer neutralizing antibodies against botulinum toxins A, B, and E by DNA electrotransfer. Infect Immun. 2009; 77 (5): 2221-2229.
    • (2009) Infect Immun , vol.77 , Issue.5 , pp. 2221-2229
    • Trollet, C.1    Pereira, Y.2    Burgain, A.3
  • 32
    • 84878866530 scopus 로고    scopus 로고
    • Codon optimization and woodchuck hepatitis virus posttranscriptional regulatory element enhance the immune responses of DNA vaccines against infectious bursal disease virus in chickens
    • Li K, Gao L, Gao H, et al. Codon optimization and woodchuck hepatitis virus posttranscriptional regulatory element enhance the immune responses of DNA vaccines against infectious bursal disease virus in chickens. Virus Res. 2013; 175 (2): 120-127.
    • (2013) Virus Res , vol.175 , Issue.2 , pp. 120-127
    • Li, K.1    Gao, L.2    Gao, H.3
  • 33
    • 84881558172 scopus 로고    scopus 로고
    • Codon-optimized expression of fish iridovirus capsid protein in yeast and its application as an oral vaccine candidate
    • Seo JY, Chung HJ, Kim TJ. Codon-optimized expression of fish iridovirus capsid protein in yeast and its application as an oral vaccine candidate. J Fish Dis. 2013; 36 (9): 763-768.
    • (2013) J Fish Dis , vol.36 , Issue.9 , pp. 763-768
    • Seo, J.Y.1    Chung, H.J.2    Kim, T.J.3
  • 34
    • 84885371951 scopus 로고    scopus 로고
    • Expression of chicken parvovirus VP2 in chicken embryo fibroblasts requires codon optimization for production of naked DNA and vectored meleagrid herpesvirus type 1 vaccines
    • Spatz SJ, Volkening JD, Mullis R, et al. Expression of chicken parvovirus VP2 in chicken embryo fibroblasts requires codon optimization for production of naked DNA and vectored meleagrid herpesvirus type 1 vaccines. Virus Genes. 2013; 47 (2): 259-267.
    • (2013) Virus Genes , vol.47 , Issue.2 , pp. 259-267
    • Spatz, S.J.1    Volkening, J.D.2    Mullis, R.3
  • 35
    • 84906914729 scopus 로고    scopus 로고
    • Improving DNA vaccine performance through vector design
    • Williams JA. Improving DNA vaccine performance through vector design. Curr Gene Ther. 2014; 14 (3): 170-189.
    • (2014) Curr Gene Ther , vol.14 , Issue.3 , pp. 170-189
    • Williams, J.A.1
  • 36
    • 77954958354 scopus 로고    scopus 로고
    • Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines
    • Zhu Y, Lu F, Dai Y, et al. Synergistic enhancement of immunogenicity and protection in mice against Schistosoma japonicum with codon optimization and electroporation delivery of SjTPI DNA vaccines. Vaccine. 2010; 28 (32): 5347-5355.
    • (2010) Vaccine , vol.28 , Issue.32 , pp. 5347-5355
    • Zhu, Y.1    Lu, F.2    Dai, Y.3
  • 37
    • 84890872866 scopus 로고    scopus 로고
    • COStar: A D-star Lite-based dynamic search algorithm for codon optimization
    • Liu X, Deng R, Wang J, et al. COStar: a D-star Lite-based dynamic search algorithm for codon optimization. J Theor Biol. 2014; 344: 19-30.
    • (2014) J Theor Biol , vol.344 , pp. 19-30
    • Liu, X.1    Deng, R.2    Wang, J.3
  • 38
    • 84937546310 scopus 로고    scopus 로고
    • SwiftLib: Rapid degenerate-codon-library optimization through dynamic programming
    • Jacobs TM, Yumerefendi H, Kuhlman B, et al. SwiftLib: rapid degenerate-codon-library optimization through dynamic programming. Nucleic Acids Res. 2015;43(5):e34.
    • (2015) Nucleic Acids Res , vol.43 , Issue.5 , pp. e34
    • Jacobs, T.M.1    Yumerefendi, H.2    Kuhlman, B.3
  • 39
    • 67349149122 scopus 로고    scopus 로고
    • Plasmodium: Mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity
    • Dobano C, Sedegah M, Rogers WO, et al. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity. Exp Parasitol. 2009; 122 (2): 112-123.
    • (2009) Exp Parasitol , vol.122 , Issue.2 , pp. 112-123
    • Dobano, C.1    Sedegah, M.2    Rogers, W.O.3
  • 40
    • 33748590843 scopus 로고    scopus 로고
    • Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guerin enhances protein expression but not protection against cercarial challenge in mice
    • Varaldo PB, Miyaji EN, Vilar MM, et al. Mycobacterial codon optimization of the gene encoding the Sm14 antigen of Schistosoma mansoni in recombinant Mycobacterium bovis Bacille Calmette-Guerin enhances protein expression but not protection against cercarial challenge in mice. FEMS Immunol Med Microbiol. 2006; 48 (1): 132-139.
    • (2006) FEMS Immunol Med Microbiol , vol.48 , Issue.1 , pp. 132-139
    • Varaldo, P.B.1    Miyaji, E.N.2    Vilar, M.M.3
  • 41
    • 84908701702 scopus 로고    scopus 로고
    • A critical analysis of codon optimization in human therapeutics
    • Mauro VP, Chappell SA. A critical analysis of codon optimization in human therapeutics. Trends Mol Med. 2014; 20 (11): 604-613.
    • (2014) Trends Mol Med , vol.20 , Issue.11 , pp. 604-613
    • Mauro, V.P.1    Chappell, S.A.2
  • 42
    • 0027155874 scopus 로고
    • In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment
    • Cheng L, Ziegelhoffer PR, Yang NS. In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA. 1993; 90 (10): 4455-4459.
    • (1993) Proc Natl Acad Sci USA , vol.90 , Issue.10 , pp. 4455-4459
    • Cheng, L.1    Ziegelhoffer, P.R.2    Yang, N.S.3
  • 43
    • 0027713229 scopus 로고
    • Gene therapy by intramuscular injection of plasmid DNA: Studies on firefly luciferase gene expression in mice
    • Manthorpe M, Cornefert-Jensen F, Hartikka J, et al. Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice. Hum Gene Ther. 1993; 4 (4): 419-431.
    • (1993) Hum Gene Ther , vol.4 , Issue.4 , pp. 419-431
    • Manthorpe, M.1    Cornefert-Jensen, F.2    Hartikka, J.3
  • 44
    • 33646840487 scopus 로고    scopus 로고
    • Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine
    • Wang S, Farfan-Arribas DJ, Shen S, et al. Relative contributions of codon usage, promoter efficiency and leader sequence to the antigen expression and immunogenicity of HIV-1 Env DNA vaccine. Vaccine. 2006; 24 (21): 4531-4540.
    • (2006) Vaccine , vol.24 , Issue.21 , pp. 4531-4540
    • Wang, S.1    Farfan-Arribas, D.J.2    Shen, S.3
  • 45
    • 30044442525 scopus 로고    scopus 로고
    • DNA immunization using a non-viral promoter
    • Vanniasinkam T, Reddy ST, Ertl HC. DNA immunization using a non-viral promoter. Virology. 2006; 344 (2): 412-420.
    • (2006) Virology , vol.344 , Issue.2 , pp. 412-420
    • Vanniasinkam, T.1    Reddy, S.T.2    Ertl, H.C.3
  • 46
    • 79951652301 scopus 로고    scopus 로고
    • Down-regulation of Prdx6 contributes to DNA vaccine induced vitiligo in mice
    • Zhou Q, Wang F, Zhang Y, et al. Down-regulation of Prdx6 contributes to DNA vaccine induced vitiligo in mice. Mol Biosyst. 2011; 7 (3): 809-816.
    • (2011) Mol Biosyst , vol.7 , Issue.3 , pp. 809-816
    • Zhou, Q.1    Wang, F.2    Zhang, Y.3
  • 47
    • 79953777976 scopus 로고    scopus 로고
    • Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers
    • Luke JM, Vincent JM, Du SX, et al. Improved antibiotic-free plasmid vector design by incorporation of transient expression enhancers. Gene Ther. 2011; 18 (4): 334-343.
    • (2011) Gene Ther , vol.18 , Issue.4 , pp. 334-343
    • Luke, J.M.1    Vincent, J.M.2    Du, S.X.3
  • 48
    • 25444456106 scopus 로고    scopus 로고
    • Minicircle DNA immobilized in bacterial ghosts: In vivo production of safe non-viral DNA delivery vehicles
    • Jechlinger W, Azimpour Tabrizi C, Lubitz W, et al. Minicircle DNA immobilized in bacterial ghosts: in vivo production of safe non-viral DNA delivery vehicles. J Mol Microbiol Biotechnol. 2004; 8 (4): 222-231.
    • (2004) J Mol Microbiol Biotechnol , vol.8 , Issue.4 , pp. 222-231
    • Jechlinger, W.1    Azimpour Tabrizi, C.2    Lubitz, W.3
  • 49
    • 78650028269 scopus 로고    scopus 로고
    • A robust system for production of minicircle DNA vectors
    • Kay MA, He CY, Chen ZY. A robust system for production of minicircle DNA vectors. Nat Biotechnol. 2010; 28 (12): 1287-1289.
    • (2010) Nat Biotechnol , vol.28 , Issue.12 , pp. 1287-1289
    • Kay, M.A.1    He, C.Y.2    Chen, Z.Y.3
  • 50
    • 79952187756 scopus 로고    scopus 로고
    • Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of alpha-L-iduronidase in mice with mucopolysaccharidosis type i
    • Osborn MJ, McElmurry RT, Lees CJ, et al. Minicircle DNA-based gene therapy coupled with immune modulation permits long-term expression of alpha-L-iduronidase in mice with mucopolysaccharidosis type I. Mol Ther. 2011; 19 (3): 450-460.
    • (2011) Mol Ther , vol.19 , Issue.3 , pp. 450-460
    • Osborn, M.J.1    McElmurry, R.T.2    Lees, C.J.3
  • 51
    • 79955813305 scopus 로고    scopus 로고
    • Minicircle-oriP-IFNgamma: A novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma
    • Zuo Y, Wu J, Xu Z, et al. Minicircle-oriP-IFNgamma: a novel targeted gene therapeutic system for EBV positive human nasopharyngeal carcinoma. PLoS One. 2011; 6 (5): e19407.
    • (2011) PLoS One , vol.6 , Issue.5 , pp. e19407
    • Zuo, Y.1    Wu, J.2    Xu, Z.3
  • 52
    • 84881317423 scopus 로고    scopus 로고
    • Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses
    • Dietz WM, Skinner NE, Hamilton SE, et al. Minicircle DNA is superior to plasmid DNA in eliciting antigen-specific CD8+ T-cell responses. Mol Ther. 2013; 21 (8): 1526-1535.
    • (2013) Mol Ther , vol.21 , Issue.8 , pp. 1526-1535
    • Dietz, W.M.1    Skinner, N.E.2    Hamilton, S.E.3
  • 53
    • 84877015804 scopus 로고    scopus 로고
    • A mini-intronic plasmid (MIP): A novel robust transgene expression vector in vivo and in vitro
    • Lu J, Zhang F, Kay MA. A mini-intronic plasmid (MIP): a novel robust transgene expression vector in vivo and in vitro. Mol Ther. 2013; 21 (5): 954-963.
    • (2013) Mol Ther , vol.21 , Issue.5 , pp. 954-963
    • Lu, J.1    Zhang, F.2    Kay, M.A.3
  • 54
    • 84893498955 scopus 로고    scopus 로고
    • In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses
    • Wang Q, Jiang W, Chen Y, et al. In vivo electroporation of minicircle DNA as a novel method of vaccine delivery to enhance HIV-1-specific immune responses. J Virol. 2014; 88 (4): 1924-1934.
    • (2014) J Virol , vol.88 , Issue.4 , pp. 1924-1934
    • Wang, Q.1    Jiang, W.2    Chen, Y.3
  • 55
    • 7044263390 scopus 로고    scopus 로고
    • Vaccine adjuvants: Current state and future trends
    • Petrovsky N, Aguilar JC. Vaccine adjuvants: current state and future trends. Immunol Cell Biol. 2004; 82 (5): 488-496.
    • (2004) Immunol Cell Biol , vol.82 , Issue.5 , pp. 488-496
    • Petrovsky, N.1    Aguilar, J.C.2
  • 56
    • 79961167250 scopus 로고    scopus 로고
    • DNA released from dying host cells mediates aluminum adjuvant activity
    • Marichal T, Ohata K, Bedoret D, et al. DNA released from dying host cells mediates aluminum adjuvant activity. Nat Med. 2011; 17 (8): 996-1002.
    • (2011) Nat Med , vol.17 , Issue.8 , pp. 996-1002
    • Marichal, T.1    Ohata, K.2    Bedoret, D.3
  • 57
    • 0033588543 scopus 로고    scopus 로고
    • Enhancement of DNA vaccine potency using conventional aluminum adjuvants
    • Ulmer JB, DeWitt CM, Chastain M, et al. Enhancement of DNA vaccine potency using conventional aluminum adjuvants. Vaccine. 1999; 18 (1-2): 18-28.
    • (1999) Vaccine , vol.18 , Issue.12 , pp. 18-28
    • Ulmer, J.B.1    DeWitt, C.M.2    Chastain, M.3
  • 58
    • 84862766439 scopus 로고    scopus 로고
    • Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii
    • Khosroshahi KH, Ghaffarifar F, Sharifi Z, et al. Comparing the effect of IL-12 genetic adjuvant and alum non-genetic adjuvant on the efficiency of the cocktail DNA vaccine containing plasmids encoding SAG-1 and ROP-2 of Toxoplasma gondii. Parasitol Res. 2012; 111 (1): 403-411.
    • (2012) Parasitol Res , vol.111 , Issue.1 , pp. 403-411
    • Khosroshahi, K.H.1    Ghaffarifar, F.2    Sharifi, Z.3
  • 59
    • 78651250984 scopus 로고    scopus 로고
    • Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
    • Cristillo AD, Ferrari MG, Hudacik L, et al. Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations. J Gen Virol. 2011; 92 (Pt 1): 128-140.
    • (2011) J Gen Virol , vol.92 , pp. 128-140
    • Cristillo, A.D.1    Ferrari, M.G.2    Hudacik, L.3
  • 60
    • 77955660585 scopus 로고    scopus 로고
    • A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery
    • Karkada M, Weir GM, Quinton T, et al. A liposome-based platform, VacciMax, and its modified water-free platform DepoVax enhance efficacy of in vivo nucleic acid delivery. Vaccine. 2010; 28 (38): 6176-6182.
    • (2010) Vaccine , vol.28 , Issue.38 , pp. 6176-6182
    • Karkada, M.1    Weir, G.M.2    Quinton, T.3
  • 61
    • 84895918110 scopus 로고    scopus 로고
    • Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection
    • Liu J, Wu J, Wang B, et al. Oral vaccination with a liposome-encapsulated influenza DNA vaccine protects mice against respiratory challenge infection. J Med Virol. 2014; 86 (5): 886-894.
    • (2014) J Med Virol , vol.86 , Issue.5 , pp. 886-894
    • Liu, J.1    Wu, J.2    Wang, B.3
  • 62
    • 84893321248 scopus 로고    scopus 로고
    • CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice
    • Ma J, Wang H, Zheng X, et al. CpG/Poly (I:C) mixed adjuvant priming enhances the immunogenicity of a DNA vaccine against eastern equine encephalitis virus in mice. Int Immunopharmacol. 2014; 19 (1): 74-80.
    • (2014) Int Immunopharmacol , vol.19 , Issue.1 , pp. 74-80
    • Ma, J.1    Wang, H.2    Zheng, X.3
  • 63
    • 84865571191 scopus 로고    scopus 로고
    • TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification
    • Oldenburg M, Kruger A, Ferstl R, et al. TLR13 recognizes bacterial 23S rRNA devoid of erythromycin resistance-forming modification. Science. 2012; 337 (6098): 1111-1115.
    • (2012) Science , vol.337 , Issue.6098 , pp. 1111-1115
    • Oldenburg, M.1    Kruger, A.2    Ferstl, R.3
  • 64
    • 84862309577 scopus 로고    scopus 로고
    • CAF05: Cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice
    • Hansen J, Lindenstrom T, Lindberg-Levin J, et al. CAF05: cationic liposomes that incorporate synthetic cord factor and poly(I:C) induce CTL immunity and reduce tumor burden in mice. Cancer Immunol Immunother. 2012; 61 (6): 893-903.
    • (2012) Cancer Immunol Immunother , vol.61 , Issue.6 , pp. 893-903
    • Hansen, J.1    Lindenstrom, T.2    Lindberg-Levin, J.3
  • 65
    • 84905235486 scopus 로고    scopus 로고
    • Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine
    • Sajadian A, Tabarraei A, Soleimanjahi H, et al. Comparing the effect of Toll-like receptor agonist adjuvants on the efficiency of a DNA vaccine. Arch Virol. 2014; 159 (8): 1951-1960.
    • (2014) Arch Virol , vol.159 , Issue.8 , pp. 1951-1960
    • Sajadian, A.1    Tabarraei, A.2    Soleimanjahi, H.3
  • 66
    • 84900343586 scopus 로고    scopus 로고
    • Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. Aeruginosa infection
    • Jiang M, Yao J, Feng G. Protective effect of DNA vaccine encoding pseudomonas exotoxin A and PcrV against acute pulmonary P. aeruginosa infection. PLoS One. 2014; 9 (5): e96609.
    • (2014) PLoS One , vol.9 , Issue.5 , pp. e96609
    • Jiang, M.1    Yao, J.2    Feng, G.3
  • 67
    • 84984859713 scopus 로고    scopus 로고
    • CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST
    • Lu J, Jiang S, Ye S, et al. CpG oligodeoxynucleotide ligand potentiates the activity of the pVAX1-Sj26GST. Biomed Rep. 2013; 1 (4): 609-613.
    • (2013) Biomed Rep , vol.1 , Issue.4 , pp. 609-613
    • Lu, J.1    Jiang, S.2    Ye, S.3
  • 68
    • 84938287734 scopus 로고    scopus 로고
    • Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines
    • Yu Y, Ma Y, Wh X, et al. Combinations of various CpG motifs cloned into plasmid backbone modulate and enhance protective immunity of viral replicon DNA anthrax vaccines. Med Microbiol Immunol. 2015;204(4):481-491.
    • (2015) Med Microbiol Immunol , vol.204 , Issue.4 , pp. 481-491
    • Yu, Y.1    Ma, Y.2    Wh, X.3
  • 69
    • 78651410969 scopus 로고    scopus 로고
    • Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine
    • Luke JM, Simon GG, Soderholm J, et al. Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine. J Virol. 2011; 85 (3): 1370-1383.
    • (2011) J Virol , vol.85 , Issue.3 , pp. 1370-1383
    • Luke, J.M.1    Simon, G.G.2    Soderholm, J.3
  • 70
    • 84873046317 scopus 로고    scopus 로고
    • A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant
    • Martinez-Gil L, Goff PH, Hai R, et al. A Sendai virus-derived RNA agonist of RIG-I as a virus vaccine adjuvant. J Virol. 2013; 87 (3): 1290-1300.
    • (2013) J Virol , vol.87 , Issue.3 , pp. 1290-1300
    • Martinez-Gil, L.1    Goff, P.H.2    Hai, R.3
  • 71
    • 84907333705 scopus 로고    scopus 로고
    • Nucleic acid sensing by T cells initiates Th2 cell differentiation
    • Imanishi T, Ishihara C, Badr Mel S, et al. Nucleic acid sensing by T cells initiates Th2 cell differentiation. Nat Commun. 2014; 5: 3566.
    • (2014) Nat Commun , vol.5 , pp. 3566
    • Imanishi, T.1    Ishihara, C.2    Badr Mel, S.3
  • 72
    • 79952184381 scopus 로고    scopus 로고
    • DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity
    • Lladser A, Mougiakakos D, Tufvesson H, et al. DAI (DLM-1/ZBP1) as a genetic adjuvant for DNA vaccines that promotes effective antitumor CTL immunity. Mol Ther. 2011; 19 (3): 594-601.
    • (2011) Mol Ther , vol.19 , Issue.3 , pp. 594-601
    • Lladser, A.1    Mougiakakos, D.2    Tufvesson, H.3
  • 73
    • 0031066827 scopus 로고    scopus 로고
    • Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
    • Geissler M, Gesien A, Tokushige K, et al. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol. 1997; 158 (3): 1231-1237.
    • (1997) J Immunol , vol.158 , Issue.3 , pp. 1231-1237
    • Geissler, M.1    Gesien, A.2    Tokushige, K.3
  • 74
    • 0034715317 scopus 로고    scopus 로고
    • Co-administration of IL-2 enhances antigen-specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhoea virus
    • Nobiron I, Thompson I, Brownlie J, et al. Co-administration of IL-2 enhances antigen-specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhoea virus. Vet Microbiol. 2000; 76 (2): 129-142.
    • (2000) Vet Microbiol , vol.76 , Issue.2 , pp. 129-142
    • Nobiron, I.1    Thompson, I.2    Brownlie, J.3
  • 75
    • 70350257662 scopus 로고    scopus 로고
    • Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice
    • Hu H, Tao L, Wang Y, et al. Enhancing immune responses against SARS-CoV nucleocapsid DNA vaccine by co-inoculating interleukin-2 expressing vector in mice. Biotechnol Lett. 2009; 31 (11): 1685-1693.
    • (2009) Biotechnol Lett , vol.31 , Issue.11 , pp. 1685-1693
    • Hu, H.1    Tao, L.2    Wang, Y.3
  • 76
    • 0032210975 scopus 로고    scopus 로고
    • Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes
    • Kim JJ, Nottingham LK, Wilson DM, et al. Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes. Vaccine. 1998; 16 (19): 1828-1835.
    • (1998) Vaccine , vol.16 , Issue.19 , pp. 1828-1835
    • Kim, J.J.1    Nottingham, L.K.2    Wilson, D.M.3
  • 77
    • 0032959691 scopus 로고    scopus 로고
    • Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV
    • Kim JJ, Simbiri KA, Sin JI, et al. Cytokine molecular adjuvants modulate immune responses induced by DNA vaccine constructs for HIV-1 and SIV. J Interferon Cytokine Res. 1999; 19 (1): 77-84.
    • (1999) J Interferon Cytokine Res , vol.19 , Issue.1 , pp. 77-84
    • Kim, J.J.1    Simbiri, K.A.2    Sin, J.I.3
  • 78
    • 0036132847 scopus 로고    scopus 로고
    • Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice
    • Moore AC, Kong WP, Chakrabarti BK, et al. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice. J Virol. 2002; 76 (1): 243-250.
    • (2002) J Virol , vol.76 , Issue.1 , pp. 243-250
    • Moore, A.C.1    Kong, W.P.2    Chakrabarti, B.K.3
  • 79
    • 33646688663 scopus 로고    scopus 로고
    • Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections
    • Henke A, Rohland N, Zell R, et al. Co-expression of interleukin-2 by a bicistronic plasmid increases the efficacy of DNA immunization to prevent influenza virus infections. Intervirology. 2006; 49 (4): 249-252.
    • (2006) Intervirology , vol.49 , Issue.4 , pp. 249-252
    • Henke, A.1    Rohland, N.2    Zell, R.3
  • 80
    • 0032529197 scopus 로고    scopus 로고
    • Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration
    • Barouch DH, Santra S, Steenbeke TD, et al. Augmentation and suppression of immune responses to an HIV-1 DNA vaccine by plasmid cytokine/Ig administration. J Immunol. 1998; 161 (4): 1875-1882.
    • (1998) J Immunol , vol.161 , Issue.4 , pp. 1875-1882
    • Barouch, D.H.1    Santra, S.2    Steenbeke, T.D.3
  • 81
    • 3843121038 scopus 로고    scopus 로고
    • Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant
    • Barouch DH, Truitt DM, Letvin NL. Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant. Vaccine. 2004; 22 (23-24): 3092-3097.
    • (2004) Vaccine , vol.22 , Issue.2324 , pp. 3092-3097
    • Barouch, D.H.1    Truitt, D.M.2    Letvin, N.L.3
  • 82
    • 0033766645 scopus 로고    scopus 로고
    • Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination
    • Barouch DH, Santra S, Schmitz JE, et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science. 2000; 290 (5491): 486-492.
    • (2000) Science , vol.290 , Issue.5491 , pp. 486-492
    • Barouch, D.H.1    Santra, S.2    Schmitz, J.E.3
  • 83
    • 84884184837 scopus 로고    scopus 로고
    • [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice]
    • Zhu C, Yu M, Gao S, et al. [Protective immune responses induced by intranasal immunization with Mycoplasma pneumoniae P1C-IL-2 fusion DNA vaccine in mice]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2013; 29 (6): 585-588.
    • (2013) Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi , vol.29 , Issue.6 , pp. 585-588
    • Zhu, C.1    Yu, M.2    Gao, S.3
  • 84
    • 84879366583 scopus 로고    scopus 로고
    • A BCR/ABL-hIL-2 DNA vaccine enhances the immune responses in BALB/c mice
    • Qin Y, Tian H, Wang G, et al. A BCR/ABL-hIL-2 DNA vaccine enhances the immune responses in BALB/c mice. Biomed Res Int. 2013; 2013: 136492.
    • (2013) Biomed Res Int , vol.2013 , pp. 136492
    • Qin, Y.1    Tian, H.2    Wang, G.3
  • 85
    • 59849102406 scopus 로고    scopus 로고
    • KMP-11 DNA immunization significantly protects against L. Donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. Major
    • Bhaumik S, Basu R, Sen S, et al. KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major. Vaccine. 2009; 27 (9): 1306-1316.
    • (2009) Vaccine , vol.27 , Issue.9 , pp. 1306-1316
    • Bhaumik, S.1    Basu, R.2    Sen, S.3
  • 86
    • 53649110120 scopus 로고    scopus 로고
    • A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague
    • Yamanaka H, Hoyt T, Yang X, et al. A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague. Infect Immun. 2008; 76 (10): 4564-4573.
    • (2008) Infect Immun , vol.76 , Issue.10 , pp. 4564-4573
    • Yamanaka, H.1    Hoyt, T.2    Yang, X.3
  • 87
    • 33745753413 scopus 로고    scopus 로고
    • Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: A proof-of-concept study
    • Yang SH, Lee CG, Park SH, et al. Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study. Gene Ther. 2006; 13 (14): 1110-1117.
    • (2006) Gene Ther , vol.13 , Issue.14 , pp. 1110-1117
    • Yang, S.H.1    Lee, C.G.2    Park, S.H.3
  • 88
    • 84879222681 scopus 로고    scopus 로고
    • Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity
    • Naderi M, Saeedi A, Moradi A, et al. Interleukin-12 as a genetic adjuvant enhances hepatitis C virus NS3 DNA vaccine immunogenicity. Virol Sin. 2013; 28 (3): 167-173.
    • (2013) Virol Sin , vol.28 , Issue.3 , pp. 167-173
    • Naderi, M.1    Saeedi, A.2    Moradi, A.3
  • 89
    • 84903751966 scopus 로고    scopus 로고
    • Evaluation on the immune response induced by DNA vaccine encoding MIC8 co-immunized with IL-12 genetic adjuvant against Toxoplasma gondii infection
    • Zhao HG, Huang FY, Guo JL, et al. Evaluation on the immune response induced by DNA vaccine encoding MIC8 co-immunized with IL-12 genetic adjuvant against Toxoplasma gondii infection. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi. 2013; 31 (4): 284-289.
    • (2013) Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi , vol.31 , Issue.4 , pp. 284-289
    • Zhao, H.G.1    Huang, F.Y.2    Guo, J.L.3
  • 90
    • 84880927219 scopus 로고    scopus 로고
    • HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques
    • Li J, Valentin A, Kulkarni V, et al. HIV/SIV DNA vaccine combined with protein in a co-immunization protocol elicits highest humoral responses to envelope in mice and macaques. Vaccine. 2013; 31 (36): 3747-3755.
    • (2013) Vaccine , vol.31 , Issue.36 , pp. 3747-3755
    • Li, J.1    Valentin, A.2    Kulkarni, V.3
  • 91
    • 84881623207 scopus 로고    scopus 로고
    • Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery
    • Kalams SA, Parker SD, Elizaga M, et al. Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery. J Infect Dis. 2013; 208 (5): 818-829.
    • (2013) J Infect Dis , vol.208 , Issue.5 , pp. 818-829
    • Kalams, S.A.1    Parker, S.D.2    Elizaga, M.3
  • 92
    • 33244463077 scopus 로고    scopus 로고
    • Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses
    • Yoon HA, Aleyas AG, George JA, et al. Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses. Microbiol Immunol. 2006; 50 (2): 83-92.
    • (2006) Microbiol Immunol , vol.50 , Issue.2 , pp. 83-92
    • Yoon, H.A.1    Aleyas, A.G.2    George, J.A.3
  • 93
    • 84871655814 scopus 로고    scopus 로고
    • Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: Their immunity and protective efficacy in mice
    • Lu H, Xu XF, Gao N, et al. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice. Mol Immunol. 2013; 54 (2): 109-114.
    • (2013) Mol Immunol , vol.54 , Issue.2 , pp. 109-114
    • Lu, H.1    Xu, X.F.2    Gao, N.3
  • 94
    • 0037137529 scopus 로고    scopus 로고
    • Co-immunization of rhesus macaques with plasmid vectors expressing IFN-gamma, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus
    • Lena P, Villinger F, Giavedoni L, et al. Co-immunization of rhesus macaques with plasmid vectors expressing IFN-gamma, GM-CSF, and SIV antigens enhances anti-viral humoral immunity but does not affect viremia after challenge with highly pathogenic virus. Vaccine. 2002; 20 (Suppl 4): A69-A79.
    • (2002) Vaccine , vol.20 , pp. A69-A79
    • Lena, P.1    Villinger, F.2    Giavedoni, L.3
  • 95
    • 0036692980 scopus 로고    scopus 로고
    • Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration
    • ONeill E, Martinez I, Villinger F, et al. Protection by SIV VLP DNA prime/protein boost following mucosal SIV challenge is markedly enhanced by IL-12/GM-CSF co-administration. J Med Primatol. 2002; 31 (4-5): 217-227.
    • (2002) J Med Primatol , vol.31 , Issue.45 , pp. 217-227
    • Oneill, E.1    Martinez, I.2    Villinger, F.3
  • 96
    • 84908396674 scopus 로고    scopus 로고
    • Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice
    • Chen H, Gao N, Wu J, et al. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice. Immunol Lett. 2014; 162 (1 Pt A): 140-148.
    • (2014) Immunol Lett , vol.162 , Issue.1 , pp. 140-148
    • Chen, H.1    Gao, N.2    Wu, J.3
  • 97
    • 84869848516 scopus 로고    scopus 로고
    • Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine
    • Hellerstein M, Xu Y, Marino T, et al. Co-expression of HIV-1 virus-like particles and granulocyte-macrophage colony stimulating factor by GEO-D03 DNA vaccine. Hum Vaccin Immunother. 2012; 8 (11): 1654-1658.
    • (2012) Hum Vaccin Immunother , vol.8 , Issue.11 , pp. 1654-1658
    • Hellerstein, M.1    Xu, Y.2    Marino, T.3
  • 98
    • 84920532579 scopus 로고    scopus 로고
    • Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells
    • Bergamaschi C, Kulkarni V, Rosati M, et al. Intramuscular delivery of heterodimeric IL-15 DNA in macaques produces systemic levels of bioactive cytokine inducing proliferation of NK and T cells. Gene Ther. 2015; 22 (1): 76-86.
    • (2015) Gene Ther , vol.22 , Issue.1 , pp. 76-86
    • Bergamaschi, C.1    Kulkarni, V.2    Rosati, M.3
  • 99
    • 84907024463 scopus 로고    scopus 로고
    • Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice
    • Chen J, Li ZY, Huang SY, et al. Protective efficacy of Toxoplasma gondii calcium-dependent protein kinase 1 (TgCDPK1) adjuvated with recombinant IL-15 and IL-21 against experimental toxoplasmosis in mice. BMC Infect Dis. 2014; 14: 487.
    • (2014) BMC Infect Dis , vol.14 , pp. 487
    • Chen, J.1    Li, Z.Y.2    Huang, S.Y.3
  • 100
    • 84899935171 scopus 로고    scopus 로고
    • Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice
    • Li ZY, Chen J, Petersen E, et al. Synergy of mIL-21 and mIL-15 in enhancing DNA vaccine efficacy against acute and chronic Toxoplasma gondii infection in mice. Vaccine. 2014; 32 (25): 3058-3065.
    • (2014) Vaccine , vol.32 , Issue.25 , pp. 3058-3065
    • Li, Z.Y.1    Chen, J.2    Petersen, E.3
  • 101
    • 84869840329 scopus 로고    scopus 로고
    • Sequential administration of cytokine genes to enhance cellular immune responses and CD4 (+) T memory cells during DNA vaccination
    • Su B, Wang J, Zhao G, et al. Sequential administration of cytokine genes to enhance cellular immune responses and CD4 (+) T memory cells during DNA vaccination. Hum Vaccin Immunother. 2012; 8 (11): 1659-1667.
    • (2012) Hum Vaccin Immunother , vol.8 , Issue.11 , pp. 1659-1667
    • Su, B.1    Wang, J.2    Zhao, G.3
  • 102
    • 84856869561 scopus 로고    scopus 로고
    • Technologies for enhanced efficacy of DNA vaccines
    • Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines. 2012; 11 (2): 189-209.
    • (2012) Expert Rev Vaccines , vol.11 , Issue.2 , pp. 189-209
    • Saade, F.1    Petrovsky, N.2
  • 103
    • 84893361972 scopus 로고    scopus 로고
    • CTL induction by DNA vaccine with Toxoplasma gondii-HSP70 gene
    • Chu D, Moroda M, Piao LX, et al. CTL induction by DNA vaccine with Toxoplasma gondii-HSP70 gene. Parasitol Int. 2014; 63 (2): 408-416.
    • (2014) Parasitol Int , vol.63 , Issue.2 , pp. 408-416
    • Chu, D.1    Moroda, M.2    Piao, L.X.3
  • 104
    • 84878552360 scopus 로고    scopus 로고
    • PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice
    • Zhou J, Cheung AK, Tan Z, et al. PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice. J Clin Invest. 2013; 123 (6): 2629-2642.
    • (2013) J Clin Invest , vol.123 , Issue.6 , pp. 2629-2642
    • Zhou, J.1    Cheung, A.K.2    Tan, Z.3
  • 105
    • 84870838643 scopus 로고    scopus 로고
    • MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens
    • Liniger M, Summerfield A, Ruggli N. MDA5 can be exploited as efficacious genetic adjuvant for DNA vaccination against lethal H5N1 influenza virus infection in chickens. PLoS One. 2012; 7 (12): e49952.
    • (2012) PLoS One , vol.7 , Issue.12 , pp. e49952
    • Liniger, M.1    Summerfield, A.2    Ruggli, N.3
  • 106
    • 77954576021 scopus 로고    scopus 로고
    • Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination
    • Castaldello A, Sgarbanti M, Marsili G, et al. Interferon regulatory factor-1 acts as a powerful adjuvant in tat DNA based vaccination. J Cell Physiol. 2010; 224 (3): 702-709.
    • (2010) J Cell Physiol , vol.224 , Issue.3 , pp. 702-709
    • Castaldello, A.1    Sgarbanti, M.2    Marsili, G.3
  • 107
    • 85019428984 scopus 로고    scopus 로고
    • Co-administration of molecular adjuvants expressing NF-kappa B subunit p65/RelA or type-1 transactivator T-bet enhance antigen specific DNA vaccine-induced immunity
    • Shedlock DJ, Tingey C, Mahadevan L, et al. Co-administration of molecular adjuvants expressing NF-kappa B subunit p65/RelA or type-1 transactivator T-bet enhance antigen specific DNA vaccine-induced immunity. Vaccines. 2014; 2 (2): 196-215.
    • (2014) Vaccines , vol.2 , Issue.2 , pp. 196-215
    • Shedlock, D.J.1    Tingey, C.2    Mahadevan, L.3
  • 108
    • 84868345023 scopus 로고    scopus 로고
    • [Immune regulation of T-bet adjuvant on Ag85B DNA vaccine against Mycobacterium tuberculosis]
    • Chen LP, Zhang RB, Hu D, et al. [Immune regulation of T-bet adjuvant on Ag85B DNA vaccine against Mycobacterium tuberculosis]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012; 28 (7): 680-683.
    • (2012) Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi , vol.28 , Issue.7 , pp. 680-683
    • Chen, L.P.1    Zhang, R.B.2    Hu, D.3
  • 109
    • 84861585692 scopus 로고    scopus 로고
    • T-bet acts as a powerful adjuvant in Ag85B DNAbased vaccination against tuberculosis
    • Hu D, Wu J, Zhang R, et al. T-bet acts as a powerful adjuvant in Ag85B DNAbased vaccination against tuberculosis. Mol Med Rep. 2012; 6 (1): 139-144.
    • (2012) Mol Med Rep , vol.6 , Issue.1 , pp. 139-144
    • Hu, D.1    Wu, J.2    Zhang, R.3
  • 110
    • 84868111291 scopus 로고    scopus 로고
    • Short noncoding DNA fragment improve efficiencies of in vivo electroporation-mediated gene transfer
    • Peng J, Zhao Y, Mai J, et al. Short noncoding DNA fragment improve efficiencies of in vivo electroporation-mediated gene transfer. J Gene Med. 2012; 14 (9-10): 563-569.
    • (2012) J Gene Med , vol.14 , Issue.910 , pp. 563-569
    • Peng, J.1    Zhao, Y.2    Mai, J.3
  • 111
    • 84903883512 scopus 로고    scopus 로고
    • Short noncoding DNA fragments improve the immune potency of electroporation-mediated HBV DNA vaccination
    • Peng J, Shi S, Yang Z, et al. Short noncoding DNA fragments improve the immune potency of electroporation-mediated HBV DNA vaccination. Gene Ther. 2014; 21 (7): 703-708.
    • (2014) Gene Ther , vol.21 , Issue.7 , pp. 703-708
    • Peng, J.1    Shi, S.2    Yang, Z.3
  • 112
    • 77957820261 scopus 로고    scopus 로고
    • RNAi and small interfering RNAs in human disease therapeutic applications
    • Lares MR, Rossi JJ, Ouellet DL. RNAi and small interfering RNAs in human disease therapeutic applications. Trends Biotechnol. 2010; 28 (11): 570-579.
    • (2010) Trends Biotechnol , vol.28 , Issue.11 , pp. 570-579
    • Lares, M.R.1    Rossi, J.J.2    Ouellet, D.L.3
  • 113
    • 79954492561 scopus 로고    scopus 로고
    • Modulation of plasmid DNA vaccine antigen clearance by caspase 12 RNA interference potentiates vaccination
    • Geiben-Lynn R, Frimpong-Boateng K, Letvin NL. Modulation of plasmid DNA vaccine antigen clearance by caspase 12 RNA interference potentiates vaccination. Clin Vaccine Immunol. 2011; 18 (4): 533-538.
    • (2011) Clin Vaccine Immunol , vol.18 , Issue.4 , pp. 533-538
    • Geiben-Lynn, R.1    Frimpong-Boateng, K.2    Letvin, N.L.3
  • 114
    • 79953800932 scopus 로고    scopus 로고
    • RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency
    • Wang ST, Chang CC, Yen MC, et al. RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency. Gene Ther. 2011; 18 (4): 372-383.
    • (2011) Gene Ther , vol.18 , Issue.4 , pp. 372-383
    • Wang, S.T.1    Chang, C.C.2    Yen, M.C.3
  • 115
    • 79960039023 scopus 로고    scopus 로고
    • Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency
    • Kim JH, Kang TH, Noh KH, et al. Blocking the immunosuppressive axis with small interfering RNA targeting interleukin (IL)-10 receptor enhances dendritic cell-based vaccine potency. Clin Exp Immunol. 2011; 165 (2): 180-189.
    • (2011) Clin Exp Immunol , vol.165 , Issue.2 , pp. 180-189
    • Kim, J.H.1    Kang, T.H.2    Noh, K.H.3
  • 116
    • 84855341575 scopus 로고    scopus 로고
    • Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice
    • Jiang W. Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice. Vaccine. 2012; 30 (4): 758-766.
    • (2012) Vaccine , vol.30 , Issue.4 , pp. 758-766
    • Jiang, W.1
  • 117
    • 84899489828 scopus 로고    scopus 로고
    • The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma
    • Pradhan P, Qin H, Leleux JA, et al. The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma. Biomaterials. 2014; 35 (21): 5491-5504.
    • (2014) Biomaterials , vol.35 , Issue.21 , pp. 5491-5504
    • Pradhan, P.1    Qin, H.2    Leleux, J.A.3
  • 118
    • 84902890484 scopus 로고    scopus 로고
    • Summary of bi-shRNA/GM-CSF augmented autologous tumor cell immunotherapy (FANG) in advanced cancer of the liver
    • Nemunaitis J, Barve M, Orr D, et al. Summary of bi-shRNA/GM-CSF augmented autologous tumor cell immunotherapy (FANG) in advanced cancer of the liver. Oncology. 2014; 87 (1): 21-29.
    • (2014) Oncology , vol.87 , Issue.1 , pp. 21-29
    • Nemunaitis, J.1    Barve, M.2    Orr, D.3
  • 119
    • 84948382374 scopus 로고    scopus 로고
    • Modulating APOBEC expression enhances DNA vaccine immunogenicity
    • Almeida RR, Raposo RA, Coirada FC, et al. Modulating APOBEC expression enhances DNA vaccine immunogenicity. Immunol Cell Biol. 2015;93(10):868-876.
    • (2015) Immunol Cell Biol , vol.93 , Issue.10 , pp. 868-876
    • Almeida, R.R.1    Raposo, R.A.2    Coirada, F.C.3
  • 120
    • 84877785185 scopus 로고    scopus 로고
    • Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination
    • Chen YZ, Ruan GX, Yao XL, et al. Co-transfection gene delivery of dendritic cells induced effective lymph node targeting and anti-tumor vaccination. Pharm Res. 2013; 30 (6): 1502-1512.
    • (2013) Pharm Res , vol.30 , Issue.6 , pp. 1502-1512
    • Chen, Y.Z.1    Ruan, G.X.2    Yao, X.L.3
  • 121
    • 84858780815 scopus 로고    scopus 로고
    • Cancer immunotherapy via dendritic cells
    • Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat Rev Cancer. 2012; 12 (4): 265-277.
    • (2012) Nat Rev Cancer , vol.12 , Issue.4 , pp. 265-277
    • Palucka, K.1    Banchereau, J.2
  • 122
    • 84897954314 scopus 로고    scopus 로고
    • Structure-based programming of lymph-node targeting in molecular vaccines
    • Liu H, Moynihan KD, Zheng Y, et al. Structure-based programming of lymph-node targeting in molecular vaccines. Nature. 2014; 507 (7493): 519-522.
    • (2014) Nature , vol.507 , Issue.7493 , pp. 519-522
    • Liu, H.1    Moynihan, K.D.2    Zheng, Y.3
  • 123
    • 84902076453 scopus 로고    scopus 로고
    • Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes
    • Toke ER, Lorincz O, Csiszovszki Z, et al. Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes. Gene Ther. 2014; 21 (6): 566-574.
    • (2014) Gene Ther , vol.21 , Issue.6 , pp. 566-574
    • Toke, E.R.1    Lorincz, O.2    Csiszovszki, Z.3
  • 124
    • 84920972734 scopus 로고    scopus 로고
    • Targeting DNA vaccines to myeloid cells using a small peptide
    • Ye C, Choi JG, Abraham S, et al. Targeting DNA vaccines to myeloid cells using a small peptide. Eur J Immunol. 2015; 45 (1): 82-88.
    • (2015) Eur J Immunol , vol.45 , Issue.1 , pp. 82-88
    • Ye, C.1    Choi, J.G.2    Abraham, S.3
  • 125
    • 84882708425 scopus 로고    scopus 로고
    • DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice
    • Cao J, Jin Y, Li W, et al. DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice. BMC Immunol. 2013; 14: 39.
    • (2013) BMC Immunol , vol.14 , pp. 39
    • Cao, J.1    Jin, Y.2    Li, W.3
  • 126
    • 84923103556 scopus 로고    scopus 로고
    • Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8 T-cell responses against influenza virus
    • Fossum E, Grodeland G, Terhorst D, et al. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8 T-cell responses against influenza virus. Eur J Immunol. 2015;45(2):624-635.
    • (2015) Eur J Immunol , vol.45 , Issue.2 , pp. 624-635
    • Fossum, E.1    Grodeland, G.2    Terhorst, D.3
  • 127
    • 84859898868 scopus 로고    scopus 로고
    • Targeting dendritic cells with antigen via dendritic cell-associated promoters
    • Moulin V, Morgan ME, Eleveld-Trancikova D, et al. Targeting dendritic cells with antigen via dendritic cell-associated promoters. Cancer Gene Ther. 2012; 19 (5): 303-311.
    • (2012) Cancer Gene Ther , vol.19 , Issue.5 , pp. 303-311
    • Moulin, V.1    Morgan, M.E.2    Eleveld-Trancikova, D.3
  • 128
    • 27644563834 scopus 로고    scopus 로고
    • Antigen delivery via two molecules on the CD8-dendritic cell subset induces humoral immunity in the absence of conventional "danger"
    • Corbett AJ, Caminschi I, McKenzie BS, et al. Antigen delivery via two molecules on the CD8-dendritic cell subset induces humoral immunity in the absence of conventional "danger". Eur J Immunol. 2005; 35 (10): 2815-2825.
    • (2005) Eur J Immunol , vol.35 , Issue.10 , pp. 2815-2825
    • Corbett, A.J.1    Caminschi, I.2    McKenzie, B.S.3
  • 129
    • 84255170451 scopus 로고    scopus 로고
    • Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells
    • Daftarian P, Kaifer AE, Li W, et al. Peptide-conjugated PAMAM dendrimer as a universal DNA vaccine platform to target antigen-presenting cells. Cancer Res. 2011; 71 (24): 7452-7462.
    • (2011) Cancer Res , vol.71 , Issue.24 , pp. 7452-7462
    • Daftarian, P.1    Kaifer, A.E.2    Li, W.3
  • 130
    • 79959469884 scopus 로고    scopus 로고
    • The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia
    • Kataoka K, Fujihashi K, Oma K, et al. The nasal dendritic cell-targeting Flt3 ligand as a safe adjuvant elicits effective protection against fatal pneumococcal pneumonia. Infect Immun. 2011; 79 (7): 2819-2828.
    • (2011) Infect Immun , vol.79 , Issue.7 , pp. 2819-2828
    • Kataoka, K.1    Fujihashi, K.2    Oma, K.3
  • 131
    • 79960544931 scopus 로고    scopus 로고
    • Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype
    • Lahoud MH, Ahmet F, Kitsoulis S, et al. Targeting antigen to mouse dendritic cells via Clec9A induces potent CD4 T cell responses biased toward a follicular helper phenotype. J Immunol. 2011; 187 (2): 842-850.
    • (2011) J Immunol , vol.187 , Issue.2 , pp. 842-850
    • Lahoud, M.H.1    Ahmet, F.2    Kitsoulis, S.3
  • 132
    • 84856775381 scopus 로고    scopus 로고
    • CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals
    • Njongmeta LM, Bray J, Davies CJ, et al. CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals. Vaccine. 2012;30(9):1624-1635.
    • (2012) Vaccine , vol.30 , Issue.9 , pp. 1624-1635
    • Njongmeta, L.M.1    Bray, J.2    Davies, C.J.3
  • 133
    • 84921304581 scopus 로고    scopus 로고
    • Enhancement of DNA vaccine efficacy by intracellular targeting strategies
    • Freitas EB, Henriques AM, Fevereiro M, et al. Enhancement of DNA vaccine efficacy by intracellular targeting strategies. Methods Mol Biol. 2014; 1143: 33-59.
    • (2014) Methods Mol Biol , vol.1143 , pp. 33-59
    • Freitas, E.B.1    Henriques, A.M.2    Fevereiro, M.3
  • 134
    • 84903136057 scopus 로고    scopus 로고
    • Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response
    • Godinho RM, Matassoli FL, Lucas CG, et al. Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response. PLoS One. 2014; 9 (6): e99887.
    • (2014) PLoS One , vol.9 , Issue.6 , pp. e99887
    • Godinho, R.M.1    Matassoli, F.L.2    Lucas, C.G.3
  • 135
    • 84897481849 scopus 로고    scopus 로고
    • Autophagy-targeted vaccine of LC3-LpqH DNA and its protective immunity in a murine model of tuberculosis
    • Hu D, Wu J, Zhang R, et al. Autophagy-targeted vaccine of LC3-LpqH DNA and its protective immunity in a murine model of tuberculosis. Vaccine. 2014; 32 (20): 2308-2314.
    • (2014) Vaccine , vol.32 , Issue.20 , pp. 2308-2314
    • Hu, D.1    Wu, J.2    Zhang, R.3
  • 136
    • 84872610333 scopus 로고    scopus 로고
    • Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system
    • Meerak J, Wanichwecharungruang SP, Palaga T. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system. Vaccine. 2013; 31 (5): 784-790.
    • (2013) Vaccine , vol.31 , Issue.5 , pp. 784-790
    • Meerak, J.1    Wanichwecharungruang, S.P.2    Palaga, T.3
  • 137
    • 84930446416 scopus 로고    scopus 로고
    • The recombinant BCG DeltaureC:hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation
    • Saiga H, Nieuwenhuizen N, Gengenbacher M, et al. The recombinant BCG DeltaureC:hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation. J Infect Dis. 2015;211(11):1831-1841.
    • (2015) J Infect Dis , vol.211 , Issue.11 , pp. 1831-1841
    • Saiga, H.1    Nieuwenhuizen, N.2    Gengenbacher, M.3
  • 138
    • 78650155907 scopus 로고    scopus 로고
    • A short polypeptide from the herpes simplex virus type 2 ICP10 gene can induce antigen aggregation and autophagosomal degradation for enhanced immune presentation
    • Fu X, Tao L, Zhang X. A short polypeptide from the herpes simplex virus type 2 ICP10 gene can induce antigen aggregation and autophagosomal degradation for enhanced immune presentation. Hum Gene Ther. 2010; 21 (12): 1687-1696.
    • (2010) Hum Gene Ther , vol.21 , Issue.12 , pp. 1687-1696
    • Fu, X.1    Tao, L.2    Zhang, X.3
  • 139
    • 84904435383 scopus 로고    scopus 로고
    • Plasmids encoding protein aggregation domains act as molecular adjuvants for DNA vaccines
    • Capitani M, Saade F, Havas KM, et al. Plasmids encoding protein aggregation domains act as molecular adjuvants for DNA vaccines. Curr Gene Ther. 2014; 14 (3): 161-169.
    • (2014) Curr Gene Ther , vol.14 , Issue.3 , pp. 161-169
    • Capitani, M.1    Saade, F.2    Havas, K.M.3
  • 140
    • 84893774396 scopus 로고    scopus 로고
    • The effect of helper epitopes and cellular localization of an antigen on the outcome of gene gun DNA immunization
    • Smahel M, Polakova I, Duskova M, et al. The effect of helper epitopes and cellular localization of an antigen on the outcome of gene gun DNA immunization. Gene Ther. 2014; 21 (2): 225-232.
    • (2014) Gene Ther , vol.21 , Issue.2 , pp. 225-232
    • Smahel, M.1    Polakova, I.2    Duskova, M.3
  • 141
    • 80053547838 scopus 로고    scopus 로고
    • Targeting skin dendritic cells to improve intradermal vaccination
    • Romani N, Flacher V, Tripp CH, et al. Targeting skin dendritic cells to improve intradermal vaccination. Curr Top Microbiol Immunol. 2012; 351: 113-138.
    • (2012) Curr Top Microbiol Immunol , vol.351 , pp. 113-138
    • Romani, N.1    Flacher, V.2    Tripp, C.H.3
  • 142
    • 84855422153 scopus 로고    scopus 로고
    • Serum amyloid P component facilitates DNA clearance and inhibits plasmid transfection: Implications for human DNA vaccine
    • Wang Y, Guo Y, Wang X, et al. Serum amyloid P component facilitates DNA clearance and inhibits plasmid transfection: implications for human DNA vaccine. Gene Ther. 2012;19(1):70-77.
    • (2012) Gene Ther , vol.19 , Issue.1 , pp. 70-77
    • Wang, Y.1    Guo, Y.2    Wang, X.3
  • 143
    • 80051989398 scopus 로고    scopus 로고
    • Systems biology of vaccination for seasonal influenza in humans
    • Nakaya HI, Wrammert J, Lee EK, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011; 12 (8): 786-795.
    • (2011) Nat Immunol , vol.12 , Issue.8 , pp. 786-795
    • Nakaya, H.I.1    Wrammert, J.2    Lee, E.K.3
  • 144
    • 80051966191 scopus 로고    scopus 로고
    • Solving vaccine mysteries: A systems biology perspective
    • Trautmann L, Sekaly RP. Solving vaccine mysteries: a systems biology perspective. Nat Immunol. 2011; 12 (8): 729-731.
    • (2011) Nat Immunol , vol.12 , Issue.8 , pp. 729-731
    • Trautmann, L.1    Sekaly, R.P.2
  • 145
    • 80052776804 scopus 로고    scopus 로고
    • The top five "game changers" in vaccinology: Toward rational and directed vaccine development
    • Kennedy RB, Poland GA. The top five "game changers" in vaccinology: toward rational and directed vaccine development. OMICS. 2011;15(9):533-537.
    • (2011) OMICS , vol.15 , Issue.9 , pp. 533-537
    • Kennedy, R.B.1    Poland, G.A.2
  • 146
    • 80052727699 scopus 로고    scopus 로고
    • Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections
    • Poland GA, Ovsyannikova IG, Kennedy RB, et al. Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections. OMICS. 2011;15(9):625-636.
    • (2011) OMICS , vol.15 , Issue.9 , pp. 625-636
    • Poland, G.A.1    Ovsyannikova, I.G.2    Kennedy, R.B.3
  • 147
    • 84887611824 scopus 로고    scopus 로고
    • Systems biological approaches to measure and understand vaccine immunity in humans
    • Li S, Nakaya HI, Kazmin DA, et al. Systems biological approaches to measure and understand vaccine immunity in humans. Semin Immunol. 2013; 25 (3): 209-218.
    • (2013) Semin Immunol , vol.25 , Issue.3 , pp. 209-218
    • Li, S.1    Nakaya, H.I.2    Kazmin, D.A.3
  • 148
    • 79961048088 scopus 로고    scopus 로고
    • A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204)
    • Churchyard GJ, Morgan C, Adams E, et al. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204). PLoS One. 2011; 6 (8): e21225.
    • (2011) PLoS One , vol.6 , Issue.8 , pp. e21225
    • Churchyard, G.J.1    Morgan, C.2    Adams, E.3
  • 149
    • 80053078021 scopus 로고    scopus 로고
    • HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable
    • De Rosa SC, Thomas EP, Bui J, et al. HIV-DNA priming alters T cell responses to HIV-adenovirus vaccine even when responses to DNA are undetectable. J Immunol. 2011; 187 (6): 3391-3401.
    • (2011) J Immunol , vol.187 , Issue.6 , pp. 3391-3401
    • De Rosa, S.C.1    Thomas, E.P.2    Bui, J.3
  • 150
    • 77958498605 scopus 로고    scopus 로고
    • Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa
    • Jaoko W, Karita E, Kayitenkore K, et al. Safety and immunogenicity study of Multiclade HIV-1 adenoviral vector vaccine alone or as boost following a multiclade HIV-1 DNA vaccine in Africa. PLoS One. 2010; 5 (9): e12873.
    • (2010) PLoS One , vol.5 , Issue.9 , pp. e12873
    • Jaoko, W.1    Karita, E.2    Kayitenkore, K.3
  • 151
    • 80052624529 scopus 로고    scopus 로고
    • Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: A randomized clinical trial
    • Koblin BA, Casapia M, Morgan C, et al. Safety and immunogenicity of an HIV adenoviral vector boost after DNA plasmid vaccine prime by route of administration: a randomized clinical trial. PLoS One. 2011; 6 (9): e24517.
    • (2011) PLoS One , vol.6 , Issue.9 , pp. e24517
    • Koblin, B.A.1    Casapia, M.2    Morgan, C.3
  • 152
    • 81855182191 scopus 로고    scopus 로고
    • DNA priming and influenza vaccine immunogenicity: Two phase 1 open label randomised clinical trials
    • Ledgerwood JE, Wei CJ, Hu Z, et al. DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials. Lancet Infect Dis. 2011; 11 (12): 916-924.
    • (2011) Lancet Infect Dis , vol.11 , Issue.12 , pp. 916-924
    • Ledgerwood, J.E.1    Wei, C.J.2    Hu, Z.3
  • 153
    • 84883224523 scopus 로고    scopus 로고
    • A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus
    • Fournillier A, Frelin L, Jacquier E, et al. A heterologous prime/boost vaccination strategy enhances the immunogenicity of therapeutic vaccines for hepatitis C virus. J Infect Dis. 2013; 208 (6): 1008-1019.
    • (2013) J Infect Dis , vol.208 , Issue.6 , pp. 1008-1019
    • Fournillier, A.1    Frelin, L.2    Jacquier, E.3
  • 154
    • 84874015160 scopus 로고    scopus 로고
    • DNA prime/Adenovirus boost malaria vaccine encoding P. Falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity
    • Chuang I, Sedegah M, Cicatelli S, et al. DNA prime/Adenovirus boost malaria vaccine encoding P. falciparum CSP and AMA1 induces sterile protection associated with cell-mediated immunity. PLoS One. 2013; 8 (2): e55571.
    • (2013) PLoS One , vol.8 , Issue.2 , pp. e55571
    • Chuang, I.1    Sedegah, M.2    Cicatelli, S.3
  • 155
    • 84871938556 scopus 로고    scopus 로고
    • Prime-boost BCG vaccination with DNA vaccines based in beta-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model
    • Cervantes-Villagrana AR, Hernandez-Pando R, Biragyn A, et al. Prime-boost BCG vaccination with DNA vaccines based in beta-defensin-2 and mycobacterial antigens ESAT6 or Ag85B improve protection in a tuberculosis experimental model. Vaccine. 2013; 31 (4): 676-684.
    • (2013) Vaccine , vol.31 , Issue.4 , pp. 676-684
    • Cervantes-Villagrana, A.R.1    Hernandez-Pando, R.2    Biragyn, A.3
  • 156
    • 84871687263 scopus 로고    scopus 로고
    • A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Abeta42 DNA vaccine for Alzheimer disease
    • Lambracht-Washington D, Qu BX, Fu M, et al. A peptide prime-DNA boost immunization protocol provides significant benefits as a new generation Abeta42 DNA vaccine for Alzheimer disease. J Neuroimmunol. 2013; 254 (1-2): 63-68.
    • (2013) J Neuroimmunol , vol.254 , Issue.12 , pp. 63-68
    • Lambracht-Washington, D.1    Qu, B.X.2    Fu, M.3
  • 157
    • 84880206390 scopus 로고    scopus 로고
    • DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults
    • Khurana S, Wu J, Dimitrova M, et al. DNA priming prior to inactivated influenza A(H5N1) vaccination expands the antibody epitope repertoire and increases affinity maturation in a boost-interval-dependent manner in adults. J Infect Dis. 2013; 208 (3): 413-417.
    • (2013) J Infect Dis , vol.208 , Issue.3 , pp. 413-417
    • Khurana, S.1    Wu, J.2    Dimitrova, M.3
  • 158
    • 84880191764 scopus 로고    scopus 로고
    • Prime-boost interval matters: A randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect
    • Ledgerwood JE, Zephir K, Hu Z, et al. Prime-boost interval matters: a randomized phase 1 study to identify the minimum interval necessary to observe the H5 DNA influenza vaccine priming effect. J Infect Dis. 2013; 208 (3): 418-422.
    • (2013) J Infect Dis , vol.208 , Issue.3 , pp. 418-422
    • Ledgerwood, J.E.1    Zephir, K.2    Hu, Z.3
  • 159
    • 84938248921 scopus 로고    scopus 로고
    • DNA vaccines, electroporation and their applications in cancer treatment
    • Lee SH, Danishmalik SN, Sin JI. DNA vaccines, electroporation and their applications in cancer treatment. Hum Vaccin Immunother. 2015; 11 (8): 1889-1900.
    • (2015) Hum Vaccin Immunother , vol.11 , Issue.8 , pp. 1889-1900
    • Lee, S.H.1    Danishmalik, S.N.2    Sin, J.I.3
  • 160
    • 84921405665 scopus 로고    scopus 로고
    • Electroporation-enhanced delivery of nucleic acid vaccines
    • Broderick KE, Humeau LM. Electroporation-enhanced delivery of nucleic acid vaccines. Expert Rev Vaccines. 2015; 14 (2): 195-204.
    • (2015) Expert Rev Vaccines , vol.14 , Issue.2 , pp. 195-204
    • Broderick, K.E.1    Humeau, L.M.2
  • 161
    • 84904895500 scopus 로고    scopus 로고
    • Nanoparticles for DNA vaccine delivery
    • Shah MA, He N, Li Z, et al. Nanoparticles for DNA vaccine delivery. J Biomed Nanotechnol. 2014; 10 (9): 2332-2349.
    • (2014) J Biomed Nanotechnol , vol.10 , Issue.9 , pp. 2332-2349
    • Shah, M.A.1    He, N.2    Li, Z.3
  • 162
  • 163
    • 84926435038 scopus 로고    scopus 로고
    • Liposomes as vaccine delivery systems: A review of the recent advances
    • Schwendener RA. Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccines. 2014; 2 (6): 159-182.
    • (2014) Ther Adv Vaccines , vol.2 , Issue.6 , pp. 159-182
    • Schwendener, R.A.1
  • 164
    • 84897494777 scopus 로고    scopus 로고
    • A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation
    • Hooper JW, Moon JE, Paolino KM, et al. A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for haemorrhagic fever with renal syndrome delivered by intramuscular electroporation. Clin Microbiol Infect. 2014; 20 (Suppl 5): 110-117.
    • (2014) Clin Microbiol Infect , vol.20 , pp. 110-117
    • Hooper, J.W.1    Moon, J.E.2    Paolino, K.M.3
  • 165
    • 84938614585 scopus 로고    scopus 로고
    • HIV-DNA given with or without Intradermal electroporation is safe and highly immunogenic in healthy Swedish HIV-1 DNA/MVA vaccinees: A phase i randomized trial
    • Nilsson C, Hejdeman B, Godoy-Ramirez K, et al. HIV-DNA given with or without Intradermal electroporation is safe and highly immunogenic in healthy Swedish HIV-1 DNA/MVA vaccinees: a phase I randomized trial. PLoS One. 2015; 10 (6): e0131748.
    • (2015) PLoS One , vol.10 , Issue.6 , pp. e0131748
    • Nilsson, C.1    Hejdeman, B.2    Godoy-Ramirez, K.3
  • 166
    • 84944449690 scopus 로고    scopus 로고
    • Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans
    • Borggren M, Nielsen J, Bragstad K, et al. Vector optimization and needle-free intradermal application of a broadly protective polyvalent influenza A DNA vaccine for pigs and humans. Hum Vaccin Immunother. 2015; 11 (8): 1983-1990.
    • (2015) Hum Vaccin Immunother , vol.11 , Issue.8 , pp. 1983-1990
    • Borggren, M.1    Nielsen, J.2    Bragstad, K.3
  • 167
    • 84876002357 scopus 로고    scopus 로고
    • DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial
    • Graham BS, Enama ME, Nason MC, et al. DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial. PLoS One. 2013; 8 (4): e59340.
    • (2013) PLoS One , vol.8 , Issue.4 , pp. e59340
    • Graham, B.S.1    Enama, M.E.2    Nason, M.C.3
  • 168
    • 79958237653 scopus 로고    scopus 로고
    • Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization
    • Chen X, Fernando GJ, Crichton ML, et al. Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization. J Control Release. 2011; 152 (3): 349-355.
    • (2011) J Control Release , vol.152 , Issue.3 , pp. 349-355
    • Chen, X.1    Fernando, G.J.2    Crichton, M.L.3
  • 169
    • 84879985510 scopus 로고    scopus 로고
    • Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice
    • Pearson FE, McNeilly CL, Crichton ML, et al. Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice. Plos One. 2013; 8 (7): e67888.
    • (2013) Plos One , vol.8 , Issue.7 , pp. e67888
    • Pearson, F.E.1    McNeilly, C.L.2    Crichton, M.L.3
  • 170
    • 7444262791 scopus 로고    scopus 로고
    • Cationic submicron emulsions for pulmonary DNA immunization
    • Bivas-Benita M, Oudshoorn M, Romeijn S, et al. Cationic submicron emulsions for pulmonary DNA immunization. J Control Release. 2004; 100 (1): 145-155.
    • (2004) J Control Release , vol.100 , Issue.1 , pp. 145-155
    • Bivas-Benita, M.1    Oudshoorn, M.2    Romeijn, S.3
  • 171
    • 1842479868 scopus 로고    scopus 로고
    • Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A∗0201-restricted T-cell epitopes of Mycobacterium tuberculosis
    • Bivas-Benita M, Van Meijgaarden KE, Franken KL, et al. Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A∗0201-restricted T-cell epitopes of Mycobacterium tuberculosis. Vaccine. 2004; 22 (13-14): 1609-1615.
    • (2004) Vaccine , vol.22 , Issue.1314 , pp. 1609-1615
    • Bivas-Benita, M.1    Van Meijgaarden, K.E.2    Franken, K.L.3
  • 172
    • 24344494015 scopus 로고    scopus 로고
    • Pulmonary DNA vaccination: Concepts, possibilities and perspectives
    • Bivas-Benita M, Ottenhoff TH, Junginger HE, et al. Pulmonary DNA vaccination: concepts, possibilities and perspectives. J Control Release. 2005; 107 (1): 1-29.
    • (2005) J Control Release , vol.107 , Issue.1 , pp. 1-29
    • Bivas-Benita, M.1    Ottenhoff, T.H.2    Junginger, H.E.3
  • 173
    • 67349275745 scopus 로고    scopus 로고
    • Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice
    • Bivas-Benita M, Lin MY, Bal SM, et al. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice. Vaccine. 2009; 27 (30): 4010-4017.
    • (2009) Vaccine , vol.27 , Issue.30 , pp. 4010-4017
    • Bivas-Benita, M.1    Lin, M.Y.2    Bal, S.M.3
  • 174
    • 84885155651 scopus 로고    scopus 로고
    • Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection
    • Mann JF, McKay PF, Arokiasamy S, et al. Pulmonary delivery of DNA vaccine constructs using deacylated PEI elicits immune responses and protects against viral challenge infection. J Control Release. 2013; 170 (3): 452-459.
    • (2013) J Control Release , vol.170 , Issue.3 , pp. 452-459
    • Mann, J.F.1    McKay, P.F.2    Arokiasamy, S.3
  • 175
    • 84874101990 scopus 로고    scopus 로고
    • Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity
    • Bivas-Benita M, Gillard GO, Bar L, et al. Airway CD8(+) T cells induced by pulmonary DNA immunization mediate protective anti-viral immunity. Mucosal Immunol. 2013; 6 (1): 156-166.
    • (2013) Mucosal Immunol , vol.6 , Issue.1 , pp. 156-166
    • Bivas-Benita, M.1    Gillard, G.O.2    Bar, L.3
  • 176
    • 84901692006 scopus 로고    scopus 로고
    • Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization
    • Rajapaksa AE, Ho JJ, Qi A, et al. Effective pulmonary delivery of an aerosolized plasmid DNA vaccine via surface acoustic wave nebulization. Respir Res. 2014; 15: 60.
    • (2014) Respir Res , vol.15 , pp. 60
    • Rajapaksa, A.E.1    Ho, J.J.2    Qi, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.